Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Mellon

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Cancers|March 11, 2023
Simulated Adaptive Radiotherapy for Shrinking Glioblastoma Resection Cavities on a Hybrid MRI-Linear AcceleratorBeatriz Guevara, Kaylie Cullison, Danilo Maziero, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 22, 2021
Primary Vestibular Schwannoma Cells Activate p21 and RAD51-Associated DNA Repair Following Radiation-Induced DNA DamageTorin P Thielhelm, Stefania Goncalves, Scott Welford, et al.
Acta Oncologica (Stockholm, Sweden)|November 26, 2016
Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapyEric A Mellon, William H Jin, Jessica M Frakes, et al.
Cancers|August 12, 2023
A Fully Automated Post-Surgical Brain Tumor Segmentation Model for Radiation Treatment Planning and Longitudinal TrackingKarthik K Ramesh, Karen M Xu, Anuradha G Trivedi, et al.
Radiation Oncology (London, England)|May 22, 2025
Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineationJonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, et al.
Brachytherapy|October 11, 2015
Health-related quality-of-life changes due to high-dose-rate brachytherapy, low-dose-rate brachytherapy, or intensity-modulated radiation therapy for prostate cancerTobin J Strom, Alex A Cruz, Nick B Figura, et al.
Frontiers in Oncology|June 6, 2022
Deep Learning for Per-Fraction Automatic Segmentation of Gross Tumor Volume (GTV) and Organs at Risk (OARs) in Adaptive Radiotherapy of Cervical CancerAdrian L Breto, Benjamin Spieler, Olmo Zavala-Romero, et al.
Neuro-Oncology|March 4, 2024
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizonChia-Lin Tseng, K Liang Zeng, Eric A Mellon, et al.
Medical Physics|April 8, 2024
Validation of daily 0.35 T diffusion-weighted MRI for MRI-guided glioblastoma radiotherapyNatalia Lutsik, Siamak P Nejad-Davarani, Alessandro Valderrama, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well toleratedMichael D Chuong, Gregory M Springett, Jessica M Freilich, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Cancers|March 11, 2023
Simulated Adaptive Radiotherapy for Shrinking Glioblastoma Resection Cavities on a Hybrid MRI-Linear AcceleratorBeatriz Guevara, Kaylie Cullison, Danilo Maziero, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 22, 2021
Primary Vestibular Schwannoma Cells Activate p21 and RAD51-Associated DNA Repair Following Radiation-Induced DNA DamageTorin P Thielhelm, Stefania Goncalves, Scott Welford, et al.
Acta Oncologica (Stockholm, Sweden)|November 26, 2016
Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapyEric A Mellon, William H Jin, Jessica M Frakes, et al.
Cancers|August 12, 2023
A Fully Automated Post-Surgical Brain Tumor Segmentation Model for Radiation Treatment Planning and Longitudinal TrackingKarthik K Ramesh, Karen M Xu, Anuradha G Trivedi, et al.
Radiation Oncology (London, England)|May 22, 2025
Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineationJonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, et al.
Brachytherapy|October 11, 2015
Health-related quality-of-life changes due to high-dose-rate brachytherapy, low-dose-rate brachytherapy, or intensity-modulated radiation therapy for prostate cancerTobin J Strom, Alex A Cruz, Nick B Figura, et al.
Frontiers in Oncology|June 6, 2022
Deep Learning for Per-Fraction Automatic Segmentation of Gross Tumor Volume (GTV) and Organs at Risk (OARs) in Adaptive Radiotherapy of Cervical CancerAdrian L Breto, Benjamin Spieler, Olmo Zavala-Romero, et al.
Neuro-Oncology|March 4, 2024
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizonChia-Lin Tseng, K Liang Zeng, Eric A Mellon, et al.
Medical Physics|April 8, 2024
Validation of daily 0.35 T diffusion-weighted MRI for MRI-guided glioblastoma radiotherapyNatalia Lutsik, Siamak P Nejad-Davarani, Alessandro Valderrama, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well toleratedMichael D Chuong, Gregory M Springett, Jessica M Freilich, et al.
Pageof 8